Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David Jamieson

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer

Cancer Research

Oncology

2017

English

Phase 2 Multicentre Trial Investigating Intermittent and Continuous Dosing Schedules of the Poly(ADP-Ribose) Polymerase Inhibitor Rucaparib in Germline BRCA Mutation Carriers With Advanced Ovarian and Breast Cancer

British Journal of Cancer

Cancer Research

Oncology

2016

English

Related publications

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research

Medicine

2013

English

Circular RNA 0016788 Displays as a Biomarker for Tumor Progression and Poor Prognosis in Surgical Hepatocellular Carcinoma Patients

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

English

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

English

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

English

Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma

English

Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Scientific Reports

Multidisciplinary

2016

English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine

English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

English

Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David Jamieson

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

Phase 2 Multicentre Trial Investigating Intermittent and Continuous Dosing Schedules of the Poly(ADP-Ribose) Polymerase Inhibitor Rucaparib in Germline BRCA Mutation Carriers With Advanced Ovarian and Breast Cancer

Related publications

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

Circular RNA 0016788 Displays as a Biomarker for Tumor Progression and Poor Prognosis in Surgical Hepatocellular Carcinoma Patients

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma

Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma